Inform government officials and policymakers, private sector healthcare organizations, and the general public of the importance of the microbiome

Uncover, identify, and find solutions to the challenges and hurdles to the commercial success and clinical adoption of microbiome-based services and products

Regulatory Engagement

Engage the FDA and other relevant regulatory agencies to establish dialogue and find ways to collaborate and guide regulatory science and development pertaining to the microbiome

Educate policymakers about the potential of the microbiome to improve the effectiveness and efficiency of the healthcare system


Support collaboration among various entities working on the microbiome to assure the three Cs – consistency, comparability, and compatibility – are met in the following areas:

       Sample Collection

       Reference Databases

       Software Needs